Wisdom tooth Other area Chuang Lee Ren Leyland
Skip Ribbon Commands
Skip to main content
Menu
Dr  Chuang Lee Ren Leyland

Dr Chuang Lee Ren Leyland

​MBBS (S,pore), MRCP (UK), FAMS (S,pore)

Consultant

Sengkang General Hospital

Specialty: Infectious Disease

Conditions Treated by this Doctor:
Community acquired infections, Hospital acquired infections, Sepsis, Sexually Transmitted Infections.

Clinical Appointments

  • Consultant Department of General Medicine Sengkang General HospitalSengkang General Hospital
  • Consultant Department of Infectious Disease Sengkang General HospitalSengkang General Hospital

Profile

​Dr Leyland Chuang is an accredited specialist in Infectious Diseases, a member of the Royal Colleges of Physicians (UK), and a Fellow of the Academy of Medicine Singapore. He has an interest in nosocomial and urinary tract infections, and the surveillance and prevention of hospital acquired infections.

Education

  • MBBS (NUS, Singapore)
  • MRCP (UK) (RCP, United Kingdom)
  • FAMS (Academy of Medicine, Singapore)

Professional Appointments and Committee Memberships

  • ​Member, Asian Association of UTI and STI (AAUS); Committee for Development of Urological Association of Asia / Asian Association of UTI & STI Guidelines for UTI/STI, UTI section work group
  • Life member, Singapore Infectious Diseases Society

Awards

​Singapore Infectious Diseases Initiative (SIDI) Short Term Fellowship 2017

Research Interests

Publications

  1. Leyland Chuang, PA Tambyah. Catheter-associated urinary tract infection. Journal of Infection and Chemotherapy. 2021, Oct;27(10):1400-1406. doi: 10.1016/j.jiac.2021.07.022.
  2. LRL Chuang, J Cheung, SK Pada, YHG Tan and L Lin. Hospital-wide prevalence of catheter-associate urinary tract infections (CAUTIs) in Singapore: Surveillance of healthcare-associated infections using electronic medical records system. Singapore Medical Journal 2018, Dec; 59(12):660. doi: 10.11622/smedj.2018147.
  3. Leyland Chuang, Lasantha Ratnayake. Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection. International Journal of Antimicrobial Agents 2018, Oct; 52(4):521-522. doi: 10.1016/j.ijantimicag.2018.07.016.
  4. Tambyah PA, Chuang L and Chiong E. Prevention of catheter-associated UTI. In: Bjerklund Johansen TE, Wagenlehner FME, Matsumoto T, Cho YH, Krieger JN, Shoskes D, Naber KG, editors. Urogenital Infections and Inflammations. Duesseldorf: GMS; 2017-. DOI: 10.5680/lhuii000030 (https://books.publisso.de/publisso_gold/book/52/chapter/28).
  5. Leyland Chuang, Kyaw Thu Aung, Joanne Su Lin Kang, Merrill Lim, Charlene Kang, Ramona Alikiiteaga Gutiérrez and Hooi Ming Yap. A case note on Legionnaires’ disease caused by serogroup 1, Sequence Type ST496 in Singapore. Annals of the Academy of Medicine Singapore 2018, May; 47(5):194-195.
  6. Hyun-Sop Choe, Seung-Ju Lee, Stephen S Yang, Ryoichi Hamasuna, Shingo Yamamoto, Yong-Hyun Cho and Tetsuro Matsumoto, on behalf of the Committee for Development of the UAA-AAUS guidelines for UTI and STI. Summary of the UAA-AAUS guidelines for urinary tract infections. International Journal of Urology 2018, Mar; 25(3):175-185. doi: 10.1111/iju.13493.
  7. The National Infection Prevention and Control Guidelines for Acute Healthcare Facilities 2017, Ministry of Health, Singapore. Co-author on chapters/sections on Catheter-associated Urinary Tract Infection, Catheter-related Bloodstream Infection and MRSA Screening
  8. L Chuang, N Nashi, A Vathsala, PA Tambyah. Renal patients with asymptomatic bacteriuria do not need to be treated: results of a pilot observational audit. Healthcare Infection 2014, 19(1); 32-36.
  9. Anupama Vasudevan, Leyland Chuang, Li Jialiang, Amartya Mukhopadhyay, Eugene Yu-Yuen Goh, Paul A. Tambyah. Inappropriate empirical antimicrobial therapy for multidrug-resistant organisms in critically ill patients with pneumonia is not an independent risk factor for mortality: Results of a prospective observational study of 758 patients. Journal of Global Antimicrobial Resistance 2013, 1(3); 123-130. doi: 10.1016/j.jgar.2013.03.008.

Research Trials